Showing results (311-320 of 1,375) with videos related to
Sort By:
Pageof 138
Neuro-Oncology Advances|June 22, 2026
Possible involvement of genome-wide near-haploidy and MEN1 mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencingSatoru Kida, Takuma Nakashima, Satoshi Baba, et al.Neuro-Oncology Advances|June 29, 2026
Medulloblastoma immune microenvironment resembles early brain development and reveals novel basophil- B cell- associated signaturesGuy Dumanis, Dvir Aran, Ruty Mehrian-ShaiNeuro-Oncology Advances|July 3, 2026
Emerging blood-based biomarkers for the detection of parenchymal brain metastasis: Current progress and future perspectivesDésirée Sexauer, Elin S Gray, Helen Rizos, et al.Neuro-Oncology Advances|July 10, 2020
Label-free multiphoton imaging allows brain tumor recognition based on texture analysis-a study of 382 tumor patientsOrtrud Uckermann, Roberta Galli, Georg Mark, et al.Neuro-Oncology Advances|July 10, 2020
MRI image analysis methods and applications: an algorithmic perspective using brain tumors as an exemplarVachan Vadmal, Grant Junno, Chaitra Badve, et al.Neuro-Oncology Advances|December 3, 2021
Precision medicine biomarkers in brain metastases: applications, discordances, and obstaclesAriane Steindl, Priscilla K Brastianos, Matthias Preusser, et al.Neuro-Oncology Advances|December 3, 2021
The microenvironment of brain metastases from solid tumorsEthan S Srinivasan, Krutika Deshpande, Josh Neman, et al.Neuro-Oncology Advances|September 15, 2022
Automated detection and quantification of brain metastases on clinical MRI data using artificial neural networksIrada Pflüger, Tassilo Wald, Fabian Isensee, et al.Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.Neuro-Oncology Advances|July 10, 2026
Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trialsJohnny Duerinck, Louise Lescrauwaet, Philipp Karschnia, et al.Pageof 138